Properties of theophylline tablets dry powder coated with Eudragit ® e PO and Eudragit® L 100-55

Pharmaceutical Development and Technology

Volumn 14, Issue 6, 2009, Pages 632-641

  Sauer, Dorothea ^a   McGinity, James ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Delayed release; Dry powder coating; Eudragit E PO; Eudragit L 100 55; Hot melt extrusion; Theophylline tablets

Indexed keywords

CITRIC ACID TRIETHYL ESTER; COPOLYMER; EUDRAGIT; EUDRAGIT E PO; MICROCRYSTALLINE CELLULOSE; PLASTICIZER; THEOPHYLLINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RELEASE; DRUG SOLUBILITY; DRUG STORAGE; DRY POWDER; FILM COATING; GLASS TRANSITION TEMPERATURE; INFRARED SPECTROSCOPY; PARTICLE SIZE; PH; PRIORITY JOURNAL; TABLET FORMULATION; THERMOGRAPHY; THICKNESS;

ACRYLIC RESINS; ALGORITHMS; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG STABILITY; HUMIDITY; HYDROGEN-ION CONCENTRATION; MICROSCOPY, ELECTRON, SCANNING; PHARMACEUTIC AIDS; POLYETHYLENE GLYCOLS; POLYMETHACRYLIC ACIDS; POWDERS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; TABLETS, ENTERIC-COATED; TALC; TEMPERATURE; THEOPHYLLINE; TRANSITION TEMPERATURE;

EID: 70449336726     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450902882369     Document Type: Article

References (25)

1. Lehmann K, Dreher D. Mischbarkeit wässriger Poly (meth) acrylat-Dispersionen für Arzneimittelüberzüge. Pharm Ind 1986;48(10):1182-1183.
2. Wu C, McGinity JW. Influence of an enteric polymer on drug release rates of theophylline from pellets coated with Eudragit RS 30D. Pharm Dev Technol 2003;8(1):103-110.
3. Zheng W, McGinity JW. Influence of Eudragit® NE 30 D Blended with Eudragit® L 30 D-55 on the Release of phenylpropanolamine hydrochloride from coated pellets. Drug Dev Ind Pharm 2003;29(3):357-366.
4. Zheng W, Sauer D, McGinity JW. Influence of hydroxyethylcellulose on the drug release properties of theophylline pellets coated with Eudragit® RS 30 D. Eur J Pharm Biopharm 2005;59(1):147-154.
5. Lecomte F, Siepmann J, Walther M, MacRae RJ, Bodmeier R. Blends of enteric and GIT-insoluble polymers used for film coating: Physicochemical characterization and drug release patterns. J Control Release 2003;89(3):457-471.
6. Moustafine RI, Zaharov IM, Kemenova VA. Physicochemical characterization and drug release properties of Eudragit E PO/ Eudragit L 100-55 interpolyelectrolyte complexes. Eur J Pharm Biopharm 2006;63(1):26-36.
7. Moustafine RI, Kabanova TV, Kemenova VA, Van den Mooter G. Characteristics of interpolyelectrolyte complexes of Eudragit E100 with Eudragit L100. J Control Release 2005;103(1):191-198. (Pubitemid 40248571)
8. Katsuma M, Watanabe S, Takemura S, et al. Scintigraphic evaluation of a novel colon-targeted delivery system (CODES™) in healthy volunteers. J Pharm Sci 2004;93(5):1287-1299.
9. Vasilevska K, Djuric Z, Jovanovic M, Simov A. Preparation and dissolution characteristics of controlled release diltiazem pellets. Drug Dev Ind Pharm 1992;18(5):1649-1661.
10. Cerea M, Zheng W, Young CR, McGinity JW. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets. Int J Pharm 2004;279(1-2):127-139.
11. Zheng W, Cerea M, Sauer D, McGinity JW. Properties of theophylline tablets powder-coated with methacrylate ester copolymers. J Drug Deliv Sci Technol 2004;14(4):319-325.
12. Sauer D, Zheng W, Coots LB, McGinity JW. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55. Eur J Pharm Biopharm 2007;67:464-475.
13. Gallardo D, Assmus M, Kleinebudde P, Skalsky B. Formation of precipitates prepared by mixing countercharged (meth)acrylate copolymers. AAPS Annual Meeting 2007, San Diego, CA, USA.
14. Forster A, Hempenstall J, Tucker I, Rades T. Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int J Pharm 2001;226(1-2):147-161.
15. Li J, Chiappetta D. An investigation of the thermodynamic miscibility between VeTPGS and polymers. Int J Pharm 2008;350:212-219.
16. Fekete E, Földes E, Damsits F, Pukánszky B. Interactionstructure- property relationships in amorphous polymer blends. Polym Bull 2000;44(4):363-370.
17. Kablitz CD, Harder K, Urbanetz NA. Dry coating in a rotary fluid bed. Eur J Pharm Sci 2006;27(2-3):212-219.
18. Gallardo D, Assmus M, Kleinebudde P, Skalsky B. Analytical characterization of (meth)acrylate copolymer complexes. AAPS Annual Meeting 2007, San Diego, CA, USA.
19. Lecomte F, Siepmann J, Walther M, MacRae RJ, Bodmeier R. Polymer blends used for the aqueous coating of solid dosage forms: importance of the type of plasticizer. J Control Release 2004;99(1):1-13.
20. Dittgen M, Durrani M, Lehmann K. Acrylic polymers: A review of pharmaceutical applications. STP Pharma Sci 1997;7(6):403-437.
21. Schilling SU, Shah NH, Malick AW, Infeld MH, McGinity JW. Citric acid as a solid-state plasticizer for Eudragit RS PO. J Pharm Pharmacol 2007;59(11):1493-1500.
22. Lecomte F, Siepmann J, Walther M, MacRae RJ, Bodmeier R. pHsensitive polymer blends used as coating materials to control drug release from spherical beads: Elucidation of the underlying mass transport mechanisms. Pharm Res 2005;22(7):1129-1141. (Pubitemid 41127071)
23. Obara S, Maruyama N, Nishiyama Y, Kokubo H. Dry coating: An innovative enteric coating method using a cellulose derivative. Eur Pharm Biopharm 1999;47(1):51-59.
24. Lecomte F, Siepmann J, Walther M, MacRae RJ, Bodmeier R. Polymer blends used for the coating of multiparticulates: Comparison of aqueous and organic coating techniques. Pharm Res 2004;21(5):882-890. (Pubitemid 39011315)
25. Nyamweya N, Mehta KA, Hoag SW. Characterization of the interactions between polymethacrylate-based aqueous polymeric dispersions and aluminum lakes. J Pharm Sci 2001;90(12):1937-1947.